Exercise therapy correlates with improving renal function through modifying lipid metabolism in patients with cardiovascular disease and chronic kidney disease

Journal of Cardiology

Volumn 56, Issue 2, 2010, Pages 142-146

  Toyama, Kensuke ^a   Sugiyama, Seigo ^a   Oka, Hideki ^b   Sumida, Hitoshi ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Health Insurance Hitoyoshi General Hospital   (Japan)

Author keywords

Cardiovascular disease; Kidney; Lipids; Rehabilitation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

AGED; ANAEROBIC CAPACITY; ARTICLE; BLOOD LEVEL; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY FUNCTION; KINESIOTHERAPY; LIPID METABOLISM; MALE; MORTALITY; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; EXERCISE THERAPY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LIPID METABOLISM; MALE; TRIGLYCERIDES;

EID: 77956012193     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.06.007     Document Type: Article

References (12)

1. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffith J.L., Coresh J., Levey A.S., Sarnak M.J. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003, 41:47-55.
2. Kohzuki M., Kamimoto M., Wu X.M., Xu H.L., Kawamura T., Mori N., Nagasaka M., Kurosawa H., Minami N., Kanazawa M., Saito T., Yoshida K. Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure. J Hypertens 2001, 19:1877-1882.
3. Osato S., Onoyama K., Okuda S., Sanai T., Hori K., Fujishima M. Effect of swimming exercise on the progress of renal dysfunction in rat with focal glomerulosclerosis. Nephron 1990, 55:306-311.
4. Moinuddin I., Leehey D.J. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis 2008, 15:83-96.
5. Schaeffner E.S., Kurth T., Curhan G.C., Glynn R.J., Rexrode K.M., Baigent C., Buring J.E., Gaziano J.M. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003, 14:2084-2091.
6. Onishi T., Shimada K., Sunayama S., Ohmura H., Sumide T., Masaki Y., Fukao K., Nishitani M., Kume A., Sato H., Naito H., Kawai S., Amano A., Daida H. Effects of cardiac rehabilitation in patients with metabolic syndrome after coronary artery bypass grafting. J Cardiol 2009, 53:381-387.
7. Harper C.R., Jacobson T.A. Managing dyslipidemia in chronic kidney disease. J Am Coll Cardiol 2008, 51:2375-2384.
8. Abrass C.K. Lipid metabolism and renal disease. Contrib Nephrol 2006, 151:106-121.
9. Sharyo S., Kumagai K., Yokota-Ikeda N., Ito K., Ikeda M. Amelioration of renal ischemia-reperfusion injury by inhibition of IL-6 production in the poloxamer 407-induced mouse model of hyperlipidemia. J Pharmacol Sci 2009, 110:47-54.
10. Scheuer H., Gwinner W., Hohbach J., Gröne E.F., Brandes R.P., Malle E., Olbricht C.J., Walli A.K., Gröne H.J. Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol 2000, 278:F63-74.
11. Kelley G.A., Kelley K.S., Franklin B. Aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: a meta-analysis of randomized controlled trials. J Cardiopul Rehabil 2006, 26:131-139. quiz 140-1; discussion 142-4.
12. Athyros V.G., Kakafika A.I., Papageorgiou A.A., Pagourelias E.D., Savvatianos S.D., Elisaf M., Karagiannis A., Tziomalos K., Mikhailidis D.P. Statin-induced increase in HDL-C and renal function in coronary heart disease patients. Open Cardiovasc Med J 2007, 1:8-14.